Ignite Creation Date:
2025-12-25 @ 3:38 AM
Ignite Modification Date:
2026-07-06 @ 3:04 AM
Study NCT ID:
NCT05980702
Status:
RECRUITING
Last Update Posted:
2023-09-07
First Post:
2023-06-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
4 Courses vs 2 Courses of Pembrolizumab Combined With Carboplatin and Albumin-binding Paclitaxel of Neoadjuvant Therapy in HNSCC
Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-04-04
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-04-03
Completion Date Type:
ESTIMATED
First Submit Date:
2023-06-05
First Submit QC Date:
None
Study First Post Date:
2023-08-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-04
Last Update Post Date:
2023-09-07
Last Update Post Date Type:
ACTUAL